Yetley Elizabeth A
Office of Dietary Supplements, National Institutes of Health, Bethesda, MD 20892-7517, USA.
Am J Clin Nutr. 2007 Jan;85(1):269S-276S. doi: 10.1093/ajcn/85.1.269S.
Although multivitamins, multiminerals, and similar terms (eg, multis or multiples) are commonly used, they have no standard scientific, regulatory, or marketplace definitions. Thus, multivitamins-multiminerals refers to products with widely varied compositions and characteristics. Multivitamin-multimineral composition databases use label values as surrogates for analyzed values. However, actual vitamin and mineral amounts often deviate from label values. Vitamin and mineral bioavailability for dietary supplements also lacks a standard scientific and regulatory definition and validated in vitro and animal models that accurately reflect human bioavailabilities. Systematic information on the bioavailability and bioequivalence of vitamins and minerals in marketed products and on potential drug interactions is scarce. Because of limited information on product characteristics, our ability to directly compare results across studies, estimate changes in usage patterns or intakes over time, and generalize from published results to marketed products is problematic.
尽管多种维生素、多种矿物质以及类似术语(如多种维生素或复合维生素)被广泛使用,但它们并没有标准的科学、监管或市场定义。因此,多种维生素 - 多种矿物质产品的成分和特性差异很大。多种维生素 - 多种矿物质成分数据库使用标签值作为分析值的替代指标。然而,实际的维生素和矿物质含量往往与标签值存在偏差。膳食补充剂中维生素和矿物质的生物利用度也缺乏标准的科学和监管定义,且缺乏能准确反映人体生物利用度的体外和动物模型验证。关于市售产品中维生素和矿物质的生物利用度、生物等效性以及潜在药物相互作用的系统信息很少。由于产品特性信息有限,我们直接比较不同研究结果、估计使用模式或摄入量随时间变化以及将已发表结果推广到市售产品上的能力存在问题。